Skip to main content
IR logo

IR · Ingersoll Rand Inc.

Track IR — free
$82.60 +0.53 (+0.65%)
Market Cap
$31.52B
Shares
384.02M
Volume · Nov 18 3.02M Avg daily vol (3M) 4.36M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$82.07 Open$82.87 Day$81.91–84.75 52W close$68.54–98.76 Avg vol 30d4.4M Short int14.5M · 3.8% of shares · 2.8d Short vol71% Last earningsOct 30, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 30

Up next

Feb 12, 2027 Est · unconfirmed · in 12 wks

Latest documents

2026
Oct 30
Current report 8-K Events of Oct 27
CEO Reynal Gets New Performance Award and Extended Employment Agreement

Ingersoll Rand granted CEO Vicente Reynal 226,098 performance stock units and amended his employment agreement, extending the initial term to February 29, 2032 and raising base salary to $1,200,000.

Director or officer change, or executive pay, Regulation FD disclosure Read from the first part of this long document
3 source passages
226,098 Performance Stock Units extends the end date of the initial term from September 1, 2027 to February 29, 2032 increases annual base salary from $1,100,000 to $1,200,000 Open the document at this passage
Oct 30
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net income rises to $671.6 million on loss recovery

Ingersoll Rand Inc. reported third-quarter revenues of $2,064.9 million, up 5.6%, and net income of $671.6 million versus $245.8 million, driven by a $380.1 million recovery of acquisition related losses.

Revenue $2.06B ▲ 5.6% Net income $669.9M ▲ 174.4% Diluted EPS $1.73 ▲ 183.6%
Read from the MD&A section
3 source passages
Revenues for the three month period ended September 30, 2026 were $2,064.9 million, an increase of $109.9 million, or 5.6%, compared to $1,955.0 million for the same three month period in 2025. Net income was $671.6 million for the three month period ended September 30, 2026 compared to net income of $245.8 million in the same three month period in 2025. The decrease was primarily due to the recovery of acquisition related losses, net of $380.1 million in the 2026 period and lower restructuring charges of $13.2 million Open the document at this passage
Oct 30
Earnings call
Orders up 21% in Q3; EPS guidance raised, buyback expanded

Ingersoll Rand raised its adjusted EPS guidance to $3.58 to $3.70 after third-quarter orders rose 21% to $2.35 billion. The board also authorized a $2 billion increase to its share repurchase program.

4 source passages
Starting on Slide 6, the third quarter was A strong quarter of execution. Orders finished at $2.35 billion, up 21% year-over-year, with organic orders up 18%. We're raising adjusted EPS, excluding Q3 IEPA tariff refunds, to $3.58 to $3.70. The Board has also authorized a $2 billion increase to our share repurchase program, providing greater flexibility to compound shareholder value. Open the document at this passage
Oct 29
Current report 8-K
Third-quarter orders up 21% and revenue up 6%

Ingersoll Rand reported third-quarter 2026 orders of $2,345 million, up 21%, and revenues of $2,065 million, up 6%. The Board authorized a $2 billion increase to its share repurchase program, incremental to the $313 million remaining under the existing authorization. Updated revenue growth guidance is 5.5% to 7.0%.

Financial results
6 source passages
Third Quarter 2026 Highlights Reported orders of $2,345 million, up 21%, or up 18% organic Reported revenues of $2,065 million, up 6%, or up 4% organic The Board also authorized a $2 billion increase to the Company’s share repurchase program. This increase is incremental to the $313 million remaining under the existing authorization. Revenue Growth3 | 5.5% to 7.0% Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$8.05B
Trailing 12 months
Net income (TTM)
$1.38B
Trailing 12 months
Revenue growth YoY
+5.6%
Year over year
Operating margin
22.9%
Trailing 12 months
P / E (TTM)
23.1
Trailing earnings · reciprocal yield 4.3%
FCF yield
4.8%
TTM · current market cap
Return on invested capital
11.4%
Trailing 12 months
Net cash
−$3.39B
Latest balance sheet
Dividend yield
0.1%
Trailing 12 months
Shares change YoY
-2.7%
Year over year · fewer shares
Price change (1Y)
+11.4%
Trailing year
Short interest
3.8%
Latest settlement · 2.8 days to cover
View all 125 metrics

AI Brief

Q2 FY26 earnings call · Jul 31, 2026
Q2 FY26

TL;DR. Ingersoll Rand raised full-year 2026 revenue growth guidance to 4.5%-6.5% (200 bps higher at the midpoint) and indicated adjusted EPS would land near the high end of its range, while maintaining its adjusted EBITDA range and reporting strong Q2 orders, double-digit July order momentum, and PST margin expansion to 31.5%.

Bullish
  • + Raised full-year revenue growth guidance by 200 bps at the midpoint to 4.5%-6.5%, driven by organic volume.
  • + Reported double-digit organic order growth through the first four weeks of July, including delayed long-cycle projects coming through.
  • + Closed/signed two bolt-on acquisitions (Lone Star Blowers and Fai Filtri) adding ~$80M annual revenue and strengthening aftermarket, with 11 additional deals under LOI.
Bearish
  • − IT&S adjusted EBITDA margin declined 180 bps year-over-year to 26.8%, driven by China pricing pressure and growth investments.
  • − EMEA organic orders declined low double digits in Q2 due to timing of long-cycle projects in Europe and Middle East.
  • − Unallocated corporate costs increased to $49M from $34.6M a year ago, driven by an incentive compensation true-up.
  • − IT&S organic orders were approximately flat with delayed long-cycle projects in Europe and Middle East pressuring book-to-bill to 1.0x.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Bullish Fundamentals Strong Quant / Vol Moderate
Market backdrop VIX 25.5 · fear Equity put/call 0.71
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +1%
above
Price vs 50-day avg +5%
above
RSI (14) 53
neutral
MACD trend Negative
52-week position 45%
mid-range
Momentum
relative strength
Very Strong
1-month return +4%
trailing
6-month return +16%
trailing
YTD return +4%
this year
Relative strength +19%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $78 › 200d $81 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +92 funds added
Insider flow Distributing
Net -$831.5K over 90 days · 100% sells
Short interest Falling
3.77% of shares out · ▼ -3.1% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
916 holders — near 3-yr high, broad support
Squeeze score 53
elevated · 0–100
Fundamentals
Strong
Revenue growth +22%
Y/Y
Gross margin 140%
contracting
EPS growth −30%
Y/Y
Valuation P/E 23.1
below peers
Buyback $312.6M
remaining
Balance sheet $3.5B
net debt
Quant / Vol
risk profile
Moderate
Volatility 34%
annualized · 1-yr
Max drawdown −31%
past year
ATR 3.1%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Oct 30, 2026
for the year
Revenue growth for the year 5.5% – 7%
Adjusted EBITDA Non-GAAP $2.13B – $2.19B
Corporate cost estimate $170M
Adjusted tax rate Non-GAAP 20%
Adjusted EPS Non-GAAP $3.58 – $3.70
Share count $390.5M
Net interest expenses $230M
Free cash flow conversion of adjusted net income Non-GAAP at least 100%
Underlying operational free cash flow conversion Non-GAAP 95%
CAPEX forecast 2%
Revenue growth 5.5% – 7%
Organic growth Non-GAAP 2% – 3.5%
Growth from FX 1%
Corporate cost $170M
CAPEX 2%
Growth from M&A 2.5%
Over time
Incremental margin 30% – 40%
Q4
Organic growth Non-GAAP at least 2%
moving into next year
Pricing 1% – 2%
full-year guidance
Adjusted EPS Non-GAAP $3.58 – $3.70
Adjusted EBITDA Non-GAAP $2.13B – $2.19B
full year
Unallocated corporate costs $170M
for free cash flow
Free cash flow conversion of adjusted net income Non-GAAP at least 100%
Underlying operational free cash flow conversion Non-GAAP 95%
to finish at
Net interest expenses $230M
Previous outlook earlier release · from the 8-K filed Oct 29, 2026

Still-open targets the latest release did not restate under the same label.

Revenue Growth3 · Full Year 2026 5.5% – 7%
Adjusted EBITDA4 excl. Q3 IEEPA Tariff Refunds · Full Year 2026 $2.13B – $2.19B
Free Cash Flow to Adj. Net Income conversion4 · Full Year 2026 at least 100%
Currency5 · Full Year 2026 1%
M&A6 · Full Year 2026 2.5%
Corporate costs · Full Year 2026 $170M
Organic growth4 · Full Year 2026 2% – 3.5%
Net interest expense · Full Year 2026 $230M
Adjusted tax rate · Full Year 2026 20%
Expected FCF conversion · Full Year 2026 95%
CAPEX · Full Year 2026 2%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+1% Bullish
Price vs 50-day avg
+5% Bullish
RSI (14)
53 Neutral
MACD trend
Negative Bearish
52-week position
45% Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross) No cross
50d $78 › 200d $81 — 200d above 50d
Institutional flow Accumulating
+1% holders QoQ · +92 funds added
Insider flow Distributing
Net -$831.5K over 90 days · 100% sells
Short interest Falling
3.77% of shares out · ▼ -3.1% MoM · 2.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
916 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $69 Now $82 · 45% Range high $99
vs 200-day avg +1% vs 50-day avg +5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted diluted EPS non-GAAP $0.86 Second Quarter 2026 —
Adjusted EBITDA non-GAAP $989M Six Month Period Ended June 30, 2026 —
Adjusted EBITDA margin non-GAAP 25.4% Second Quarter 2026 —
Adjusted Net Income non-GAAP $643.9M Six Month Period Ended June 30, 2026 —
Adjusted Net Income Attributable to Ingersoll Rand Inc. non-GAAP $641M Six Month Period Ended June 30, 2026 —
Free Cash Flow non-GAAP $432.3M Six Month Period Ended June 30, 2026 —
Free Cash Flow Margin non-GAAP 11.1% Six Month Period Ended June 30, 2026 —
Industrial Technologies and Services Orders $3.18B Six Month Period Ended June 30, 2026 —
Industrial Technologies and Services Segment Adjusted EBITDA non-GAAP $820M Six Month Period Ended June 30, 2026 —
Liquidity $3.8B as of June 30, 2026 —
Orders $4.02B Six Month Period Ended June 30, 2026 —
Organic orders growth non-GAAP 1.6% Q2 2026 —
Organic revenue growth non-GAAP 4.1% Q2 2026 —
Precision and Science Technologies Orders $842.3M Six Month Period Ended June 30, 2026 —
Precision and Science Technologies Segment Adjusted EBITDA non-GAAP $256.4M Six Month Period Ended June 30, 2026 —
Segment Adjusted EBITDA (IT&S) non-GAAP $435M Second Quarter 2026 —
Segment Adjusted EBITDA (P&ST) non-GAAP $135M Second Quarter 2026 —
Segment Adjusted EBITDA Margin (IT&S) non-GAAP 26.8% Second Quarter 2026 —
Segment Adjusted EBITDA Margin (P&ST) non-GAAP 31.5% Second Quarter 2026 —
Total Segment Adjusted EBITDA non-GAAP $1.08B Six Month Period Ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Industrial Machinery — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
IR
Ingersoll Rand Inc.
this stock
$31.52B +3.6% +22.5% 23.1 3.8%
GEV
GE Vernova Inc.
$206.42B +19.3% +9.0% 20.5 2.8%
ETN
Eaton Corp plc
$130.97B +5.8% +10.3% 33.7 1.8%
SMERY
Siemens Energy AG
$117.80B — — — 0.0%
PH
Parker-Hannifin Corp
$116.11B +4.8% +18.9% 31.6 1.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
916
% held
100.8%
Net QoQ
-14.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
795
View
Short & Settlement
Short Interest Falling
Shares short
14.5M
Days to cover
2.8d
Change
-469.7K sh
View
Short Volume
Short vol %
71%
As of
Nov 17, 2026
Short Total
View
Fails to Deliver
FTD shares
24
Value
$1.8K
As of
Oct 27, 2026
View
Off-Exchange
Off-exchange %
51.2%
Week of
Oct 12, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$831.5K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Valerie Hoyle
Amount
$1.0K–$15.0K
Traded
May 21, 2025
View
Financials
Financials
Revenue (FY)
$7.7B
Net income (FY)
$581.4M
EPS diluted
$1.45
View
Buybacks
Authorized · 3 programs
$2.8B
Remaining
$312.6M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 30, 2026
This year
18

Ingersoll Rand granted CEO Vicente Reynal 226,098 performance stock units and amended his employment agreement, extending the initial term to February 29, 2032 and raising base salary to $1,200,000.

View
Proposed Sales
Value
$831.5K
Shares
9.8K
Filed
Nov 5, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 30, 2026
View
Investor Relations
Latest news
Ingersoll Rand Expands Life Scien…
Published
Nov 2, 2026
View

Performance

5D 20D 120D MTD YTD
IR -4.4% +4.4% +15.6% +2.5% +3.6%
SPY -2.3% -4.8% -2.9% -3.1% +7.4%
vs SPY -2.1% +9.2% +18.6% +5.6% -3.8%

Capital returns

Latest dividend
$0.02 / share · ex Nov 12, 2026
Paid (TTM)
$0.08 / share · 4 payouts
Dividend yield (TTM, derived)
0.10%
Full dividend history
Buyback programs · 3 active · as of Oct 28, 2026
Authorized (total)
$2.75B
Spent (derived)
$2.44B
Remaining
$312.60M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1699150 CUSIP 45687V106 13F (30d) 893 filings 816 filers Visit website Investor relations